A Practice Pathway for the Identification, Evaluation, and Management of Insomnia in Children and Adolescents With Autism Spectrum Disorders

@article{Malow2012APP,
  title={A Practice Pathway for the Identification, Evaluation, and Management of Insomnia in Children and Adolescents With Autism Spectrum Disorders},
  author={Beth A. Malow and Kelly C. Byars and Kyle P. Johnson and Shelly K Weiss and Pilar Peris Bernal and Suzanne E. Goldman and Rebecca Panzer and Daniel L. Coury and Daniel G. Glaze},
  journal={Pediatrics},
  year={2012},
  volume={130},
  pages={S106 - S124}
}
OBJECTIVE This report describes the development of a practice pathway for the identification, evaluation, and management of insomnia in children and adolescents who have autism spectrum disorders (ASDs). METHODS The Sleep Committee of the Autism Treatment Network (ATN) developed a practice pathway, based on expert consensus, to capture best practices for an overarching approach to insomnia by a general pediatrician, primary care provider, or autism medical specialist, including identification… Expand
Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder
TLDR
Recommendations were based on evidence, related evidence, principles of care, and inferences that there is currently no evidence to support the routine use of weighted blankets or specialized mattress technology for improving disrupted sleep. Expand
The Assessment and Treatment of Sleep Abnormalities in Children and Adolescents with Autism Spectrum Disorder: A Review.
  • Mandeep Rana, S. Kothare, W. Debassio
  • Medicine
  • Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent
  • 2021
TLDR
Assessment of sleep problems using both subjective and objective methods are recommended to develop an individualized approach to management of these sleep disorders in persons with ASD. Expand
Practice Tools for Screening and Monitoring Insomnia in Children and Adolescents with Autism Spectrum Disorder.
TLDR
An expert panel of child neuropsychiatry and sleep specialists, with expertise in children with neurodevelopmental disabilities, recommends performing insomnia screening of all children with ASD and considering discussion or referral to a sleep specialist when comorbid sleep disorders are suspected. Expand
Sleep in Children with Autism Spectrum Disorder
TLDR
An exemplar case is presented to integrate key constructs of the practice pathway and address arousal and sensory dysregulation in a child with ASD and anxiety disorder, and a practice pathway for promoting optimal sleep is presented. Expand
Sleep Disorders in Children and Adolescents with Autism Spectrum Disorder: Diagnosis, Epidemiology, and Management
TLDR
It is concluded that additional RCTs are desperately needed to support the management of sleep disorders in ASD with an evidence-based, precision medicine approach. Expand
Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders
TLDR
The benefits of behavioral therapies and melatonin to treat sleep problems in children with NDD are reviewed and an opportunity to improve well being and quality of life in those affected by NDD and their families is provided. Expand
Summary of studies for prevalence of sleep disorders among children with an autism spectrum disorder
Introduction: This article will discuss the prevalence and types of sleep disorders experienced by children with autism spectrum disorders (ASDs), the risk factors for the development of sleepExpand
Seeing the Whole Elephant: a scoping review of behavioral treatments for pediatric insomnia.
TLDR
Clear gaps in the literature were identified, highlighting the need for additional research in different populations, including school-age children and adolescents, racial/ethnic groups around the world, as well as youth with medical or psychiatric disorders. Expand
Sleep in Children with Neurodevelopmental Disorders : A Focus on Insomnia in Children with ADHD and ASD
TLDR
Children with NDD may require modifications to the ways in which behavioral insomnia is typically assessed and managed, and there is mounting research for the effectiveness of melatonin for treating sleep-onset problems in children with attention-deficit/hyperactivity disorder (ADHD). Expand
Barriers and facilitators to treating insomnia in children with autism spectrum disorder and other neurodevelopmental disorders: Parent and health care professional perspectives.
TLDR
A need for more education about sleep in NDDs and to develop accessible interventions, as well as the potential of a transdiagnostic approach to sleep treatment in this population of children, are highlighted. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
Pharmacologic Management of Insomnia in Children and Adolescents: Consensus Statement
TLDR
A consensus statement on the current status and future role for pharmacologic management of insomnia in children and adolescents was developed and priority should be given to insomnia studies in children with attention-deficit/hyperactivity disorder and those with pervasive developmental disorders/autism spectrum disorder. Expand
Melatonin for Insomnia in Children With Autism Spectrum Disorders
TLDR
Melatonin appears to be a safe and well-tolerated treatment for insomnia in children with autism spectrum disorders, and controlled trials to determine efficacy appear warranted. Expand
Prevalence of Diagnosed Sleep Disorders in Pediatric Primary Care Practices
TLDR
The results from this study suggest a significant need for additional education and support for primary care providers in the diagnosis and treatment of pediatric sleep disorders. Expand
Use of clonidine in children with autism spectrum disorders
TLDR
Clonidine was effective in reducing sleep initiation latency and night awakening, to a less degree in improving attention deficits hyperactivity, mood instability and aggressiveness in this cohort of 19 children with ASD. Expand
The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.
TLDR
The results of this study support the efficacy and tolerability of melatonin treatment for sleep problems in children with autistic spectrum disorder and fragile X syndrome. Expand
Melatonin for Sleep in Children with Autism: A Controlled Trial Examining Dose, Tolerability, and Outcomes
TLDR
Supplemental melatonin improved sleep latency, as measured by actigraphy, in most children at 1 or 3 mg dosages, and was effective in week 1 of treatment, maintained effects over several months, was well tolerated and safe, and showed improvement in sleep, behavior, and parenting stress. Expand
The practice of pediatric sleep medicine: results of a community survey.
TLDR
The results of this survey suggest that there are still significant gaps among practicing pediatricians both in basic knowledge about pediatric sleep disorders, and in the translation of that knowledge into clinical practice. Expand
Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population‐based study
TLDR
This study compared parent‐reported sleep characteristics in 2‐ to 5‐year‐old children with autism spectrum disorders (ASD) to children with other developmental delays (DD) and typical development (TD), finding children with ASD had marginally higher sleep onset factor scores and significantly higher night waking factor scores compared with the TD group. Expand
Pharmacologic treatment of pediatric insomnia.
TLDR
This review presents expert consensus guidelines for the use of these medications in clinical practice, with a focus on the different classes of pharmacologic agents that are most commonly prescribed. Expand
Behavioural treatment to reduce sleep problems in children with autism or fragile X syndrome.
TLDR
A parent training programme using behavioural principles to reduce sleep problems in children with autism or fragile X syndrome was evaluated and outcomes were clinically significant and maintained at follow-up. Expand
...
1
2
3
4
5
...